WebBefore joining Regeneron, Dr. Hirshberg was executive vice president, chief medical officer and head of global development at BOL Pharma, a biotech developing medical cannabis … WebNov 28, 2014 · • Counseled technology, healthcare, and life sciences companies on transactions, clinical research, data privacy, cybersecurity, …
Kim Gold - Chief Privacy Officer; Senior Associate …
WebTheir expertise and guidance are critical to advancing our mission to make a meaningful difference in cancer care. David R. Epstein Chief Executive Officer Management Team Roger Dansey, M.D. President, Research and Development Vaughn Himes, Ph.D. Chief Technical Officer Natasha Hernday Chief Business Officer Todd Simpson Chief … WebMar 2024 - Apr 20243 years 2 months. Shanghai, China. Global role with sitting office in Shanghai-dual program lead (compound CEO) & medical … installer archive corrupted or invalid
Genentech: Statements Retirement of Dr. Sandra …
WebNov 29, 2024 · Nov 29, 2024 Updated Nov 29, 2024, 3:12pm PST Tecentriq, a $3 billion-a-year cancer-fighting drug from South San Francisco-based Genentech Inc., failed a clinical trial and will be withdrawn from... WebOur newest head of Product Development (PD) and chief medical officer (CMO) knows that he has big shoes to fill. Garraway is replacing Sandra Horning, Roche's veteran PD … jfk jr flight hours